|
Delivered In Ovo, ViroGen’s New Technology For A Vaccine That Addresses The Deadly Newcastle Disease That Affects The Poultry Industry Has An Edge On Current Nasal Or Drinking Water Delivery Systems As It Is Delivered Directly Into The Embryo Prior To Hatch |
|
|
ViroGen, Inc. (VRGI-OTCPK) |
|
|
“With our in ovo vaccine the protection is up to ten weeks and it is applied only once. It is 2000 times more effective than conventional vaccines and or delivery systems and so, it lowers the cost. The fatality rates are also far less than what is current today with the present conventional delivery system.” - Paul Hogan (VRGI) (Interview published September 19, 2008) |
The Most Powerful Name In Corporate News and Information. |
|
CURRENT ISSUE | COVER ARCHIVES | INDEX | CONTACT | FINANCIALS | MARKETING SERVICES | HOME PAGE |
|
Become a member and access our interview with: IPaul Hogan, CEO (VRGI)
|
|
